Published in Gene Therapy Weekly, September 25th, 2003
Writing in the September 1, 2003, issue of the Journal of Clinical Oncology, investigators led by Dana-Farber's Glenn Dranoff, MD, report that the vaccine, made by inserting a key gene into a patient's own melanoma cells, prompted a powerful immune system attack on melanoma tumors in several patients who received it in a clinical trial. More than 3 years after the trial began, 10 of the 35 patients who...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.